Rapid appearance and local toxicity of amyloid-β plaques in a mouse model of Alzheimer’s disease
Open accessThe DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
Senile plaques accumulate over the course of decades in the brains of patients with Alzheimer's disease. A fundamental tenet of the amyloid hypothesis of Alzheimer's disease is that the deposition of amyloid-beta precedes and induces the neuronal abnormalities that underlie dementia. This idea has been challenged, however, by the suggestion that alterations in axonal trafficking and morphological abnormalities precede and lead to senile plaques. The role of microglia in accelerating or retarding these processes has been uncertain. To investigate the temporal relation between plaque formation and the changes in local neuritic architecture, we used longitudinal in vivo multiphoton microscopy to sequentially image young APPswe/PS1d9xYFP (B6C3-YFP) transgenic mice. Here we show that plaques form extraordinarily quickly, over 24 h. Within 1-2 days of a new plaque's appearance, microglia are activated and recruited to the site. Progressive neuritic changes ensue, leading to increasingly dysmorphic neurites over the next days to weeks. These data establish plaques as a critical mediator of neuritic pathology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Thus, the nidus of Aβ plaques develops from within neurites at a time course that could also fit that of plaque formation determined by multiphoton microscopy (MPM) occurring within a day [120].”
From Intraneuronal β-amyloid accumulation and synapse pathology in Alzheimer’s disease (2010) · cites this paper as [120]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In the AD brain, microglia accumulate at the site of newly formed A deposits via migration or local proliferation and may help restrict plaque growth.4,5”
From CX3CR1 Deficiency Alters Microglial Activation and Reduces Beta-Amyloid Deposition in Two Alzheimer's Disease Mouse Models (2010) · cites this paper as [5]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In the brains of AD patients and APP-overexpressing mice, plaques are surrounded by reactive microglia and astrocytes (Meyer-Luehmann et al., 2008; Serrano-Pozo et al., 2013)”
From NHE6 depletion corrects ApoE4-mediated synaptic impairments and reduces amyloid plaque load (2021) · cites this paper as Meyer-Luehmann et al., 2008
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Microglia appear rapidly (within one day) at the site of newly formed plaques [78].”
From Microglial dysfunction in brain aging and Alzheimer's disease (2014) · cites this paper as [78]
The cited source says what the claim attributes to it.
In the citing paper
“Remarkably, this MPM study of AD transgenic mouse brain in vivo also described the emergence of dystrophic neurites in areas distant from plaques that appeared and, at times, even disappeared, although intraneuronal Aβ was not examined in these neurites.”
From Intraneuronal β-amyloid accumulation and synapse pathology in Alzheimer’s disease (2010) · cites this paper as [120]
7 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED ARTICLE: A specific amyloid-β protein assembly in the brain impairs memory
Lesné, S., Koh, M. T., Kotilinek, L., Kayed, R., Glabe, C. G., Yang, A., Gallagher, M., & Ashe, K. H. (2006) · Nature · doi:10.1038/nature04533 · Cited by 2,769 · cited 1×
“It is possible that submicroscopic nuclei may be present in the cortex 23 , perhaps related to the recently reported amyloid-β oligomeric forms 24,25 , as precursors to this sudden growth.”
BackgroundRetractedThe Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864 · cited 2×
“These data thus lead to a model consistent with a prediction of the amyloid hypothesis in which amyloid deposition, activation and recruitment of microglia and local neuritic changes play out as a sequential cascade leading to neurodegeneration 1 .”
BackgroundResultWalsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291 · cited 1×
“It is possible that submicroscopic nuclei may be present in the cortex 23 , perhaps related to the recently reported amyloid-β oligomeric forms 24,25 , as precursors to this sudden growth.”
BackgroundCorrelative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice
Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996) · Science · doi:10.1126/science.274.5284.99 · Cited by 4,210 · cited 3×
“To examine whether the phenotype of plaque formation in as short a period as one week was unique to the aggressive APP/PS1 transgenic mouse model, we used a mouse line that has a slower progression of disease (Tg2576) 7 .”
BackgroundMethodImmunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse
Schenk, D., Barbour, R., Dunn, W., Gordon, G., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., et al. (1999) · Nature · doi:10.1038/22124 · Cited by 3,160
Jung, S., Aliberti, J., Graemmel, P., Sunshine, M. J., Kreutzberg, G. W., Sher, A., & Littman, D. R. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.11.4106-4114.2000 · Cited by 2,632
Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein
Games, D., Adams, D., Alessandrini, R., Barbour, R., Borthelette, P., Blackwell, C., Carr, T., Clemens, J., Donaldson, T., Gillespie, F., et al. (1995) · Nature · doi:10.1038/373523a0 · Cited by 2,516 · cited 3×
“In addition, homozygous PDAPP mice 16 were crossed with homozygous CX3CR1-GFP mice 17 , and two female PDAPP +/ − ×CX3CR1-GFP +/ − transgenic mice at the age of 18 months were used in this study and imaged for three consecutive days.”
BackgroundMethodJarrett, J. T., & Lansbury, P. T. (1993) · Cell · doi:10.1016/0092-8674(93)90635-4 · Cited by 2,178 · cited 1×
“These results are surprising because it has been generally accepted, based on in vitro studies of protein aggregation, that amyloid-β aggregation is time dependent and follows a relatively slow nucleation-dependent polymerization process 22 .”
ResultJankowsky, J. L., Fadale, D. J., Anderson, J., Xu, G. M., Gonzales, V., Jenkins, N. A., Copeland, N. G., Lee, M. K., Younkin, L. H., Wagner, S. L., et al. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh019 · Cited by 1,575
Simard, A. R., Soulet, D., Gowing, G., Julien, J.-P., & Rivest, S. (2006) · Neuron · doi:10.1016/j.neuron.2006.01.022 · Cited by 1,265 · cited 1×
“It has been proposed that activated microglia clear amyloid deposits 13 , are the nidus for initiation of amyloid fibrils 14 or restrict plaques 15 .”
Background
Cited by
Items 701–800 of 995
Lucas, H. R., & Rifkind, J. M. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-4989-8_19 · Cited by 21
Reiman, E. M., & Langbaum, J. B. S. (2009) · Imaging the Aging Brain · doi:10.1093/acprof:oso/9780195328875.003.0020 · Cited by 16
Zhang, L., Ma, Q., Yang, W., Qi, X., Yao, Z., Liu, Y., Liang, L., Wang, X., Ma, C., Huang, L., et al. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.10.023 · Cited by 15
Crowe, S. E., & Ellis‐Davies, G. C. R. (2013) · Journal of Comparative Neurology · doi:10.1002/cne.23306 · Cited by 15
de Sousa, D. M. B., Benedetti, A., Altendorfer, B., Mrowetz, H., Unger, M. S., Schallmoser, K., Aigner, L., & Kniewallner, K. M. (2023) · Aging · doi:10.18632/aging.204502 · Cited by 13
Yang, F., Zhao, J., Chen, G., Han, H., Hu, S., Wang, N., Wang, J., Chen, Y., Zhou, Z., Dai, B., et al. (2023) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2023.106432 · Cited by 15
Alteration of Metabolic Profiles during the Progression of Alzheimer’s Disease
Yu, W., Chen, L., Li, X., Han, T.-L., Yang, Y., Hu, C., Yu, W., & Lü, Y. (2023) · Brain Sciences · doi:10.3390/brainsci13101459 · Cited by 18
Specific aromatic foldamers potently inhibit spontaneous and seeded Aβ42 and Aβ43 fibril assembly
Seither, K. M., McMahon, H. A., Singh, N., Wang, H. H., Cushman-Nick, M., Montalvo, G. L., DeGrado, W. F., & Shorter, J. (2014) · Biochemical Journal · doi:10.1042/bj20131609 · Cited by 16
Macroscopic modelling of Alzheimer’s disease: difficulties and challenges
Bertsch, M., Franchi, B., Raj, A., & Tesi, M. C. (2021) · Brain Multiphysics · doi:10.1016/j.brain.2021.100040 · Cited by 16
Skaper, S. D., Facci, L., & Giusti, P. (2013) · Neurochemical Research · doi:10.1007/s11064-013-1084-2 · Cited by 17
“Activated microglia can cause neuronal cell death in vitro [27, 34, 46, 49, 50], and recent work implicates AD neurodegeneration due to the over-activation of microglia in the presence of Ab oligomers [51].”
BackgroundVerma, S., Singh, A., & Mishra, A. (2012) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2012.08.016 · Cited by 14
Attenuation of lysozyme amyloid cytotoxicity by SPION-mediated modulation of amyloid aggregation
Naik, A., Kambli, P. M., Borana, M. S., Mohanpuria, N., Ahmad, B., Kelkar-Mane, V., & Ladiwala, U. (2015) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2014.12.040 · Cited by 15
Multitasking Microglia and Alzheimer’s Disease: Diversity, Tools and Therapeutic Targets
Grubman, A., Kanninen, K. M., & Malm, T. (2016) · Journal of Molecular Neuroscience · doi:10.1007/s12031-016-0825-5 · Cited by 16
“CD11b or CX3CR1 promoter, have enabled studies of microglial functions in models of AD (Meyer-Luehmann et al. 2008; Venneti et al. 2009; Fuhrmann et al. 2010).”
BackgroundZhou, W., Hu, X., & Tam, K. Y. (2017) · Scientific Reports · doi:10.1038/s41598-017-16635-4 · Cited by 15
Oligomeric amyloid-β(1–42) induces THP-1 human monocyte adhesion and maturation
Crouse, N. R., Ajit, D., Udan, M. L. D., & Nichols, M. R. (2008) · Brain Research · doi:10.1016/j.brainres.2008.11.093 · Cited by 20
Delatour, B., Epelbaum, S., Petiet, A., & Dhénain, M. (2010) · International Journal of Alzheimer s Disease · doi:10.4061/2010/604853 · Cited by 20
“[54] demonstrated that plaques create a local microenvironment (a reservoir of bioactive molecules) that gradually promotes pathological changes in neighboring neurites within days.”
BackgroundMethodNumerical and Analytical Simulation of the Growth of Amyloid-β Plaques
Kuznetsov, A. V. (2024) · Journal of Biomechanical Engineering · doi:10.1115/1.4064969 · Cited by 15
Yassaghi, Y., Nazerian, Y., Ghasemi, M., Nazerian, A., Sayehmiri, F., Perry, G. L., & Pourbadie, H. G. (2024) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.18554 · Cited by 15
The intricate interplay between microglia and adult neurogenesis in Alzheimer’s disease
Früholz, I., & Meyer‐Luehmann, M. (2024) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2024.1456253 · Cited by 18
Self-citationRole of NLRP3 Inflammasome in Chronic Pain and Alzheimer's Disease—A Review
Moradi, F., & Mokhtari, T. (2025) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.70071 · Cited by 18
“Microglia, known as plaque ‐ associated microglia, are observed in the groups surrounding A β plaques in the brains of both AD animals [118] and humans [119].”
Crowe, S. E., & Ellis‐Davies, G. C. R. (2013) · Journal of Comparative Neurology · doi:10.1002/cne.23336 · Cited by 14
Hamanaka, G., Kubo, T., Ohtomo, R., Takase, H., Reyes‐Bricio, E., Oribe, S., Osumi, N., Lok, J. M., Lo, E. H., & Arai, K. (2020) · Glia · doi:10.1002/glia.23791 · Cited by 15
“Also, in the brain of Alzheimer's disease patients, removal of accumulated amyloid plaques by microglia has been considered as a potential therapeutic approach for the disease (Cai et al., 2014; Meyer-Luehmann et al., 2008).”
BackgroundLuyckx, T., Grootaert, C., Monge‐Morera, M., Delcour, J. A., Rousseau, F., Schymkowitz, J. W. H., & Camp, J. V. (2022) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202101032 · Cited by 16
Association between hemoglobin level and cognitive profile in old adults: A cross‐sectional survey
Yang, Y., Liu, S., Gan, J., Zhu, H., Du, X., Chen, Z., Ma, L., Meng, Q., Yang, F., Chen, H., et al. (2022) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.5806 · Cited by 14
Plaque vicinity as a hotspot of microglial turnover in a mouse model of Alzheimer's disease
Olmedillas, M., Brawek, B., Li, K., Richter, C., & Garaschuk, O. (2023) · Glia · doi:10.1002/glia.24458 · Cited by 15
“…(Davalos et al., 2012; Haruwaka et al., 2019); and parenchymal amyloid deposition in a mouse model of Alzheimer's disease (AD) causes microglial migration toward ready-to-die neurons (Fuhrmann et al., 2010) and amyloid plaques (Bolmont et al., 2008; Füger et al., 2017; Meyer-Luehmann et al., 2008).”
BackgroundXue, M., Zhu, L., Zhang, J., Qiu, J., Du, G., Qiao, Z., Jin, G., Gao, F., & Zhang, Q. (2015) · PLoS ONE · doi:10.1371/journal.pone.0120267 · Cited by 15
Prospects for Early Detection of Alzheimers Disease from Serial MR Images in Transgenic Mouse Models
Muskulus, M., Scheenstra, A. E. H., Braakman, N., Dijkstra, J., Lunel, S. M. V., Alia, A., de Groot, H. J. M., & Reiber, J. H. C. (2009) · Current Alzheimer Research · doi:10.2174/156720509790147089 · Cited by 17
Paul, A., Sharma, B., Mondal, T., Thalluri, K., Paul, S., & Mandal, B. (2015) · MedChemComm · doi:10.1039/c5md00466g · Cited by 13
Конвергенция концепций патогенеза болезни Альцгеймера
Kozin, S. A., & Makarov, A. А. (2019) · Molecular Biology · doi:10.1134/s0026898419060107 · Cited by 14
Beyond Host Defense: Deregulation of Drosophila Immunity and Age-Dependent Neurodegeneration
Arora, S., & Ligoxygakis, P. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01574 · Cited by 15
Immunotherapy for the treatment of Alzheimer's disease: amyloid-β or tau, which is the right target?
Kayed, R., Castillo-Carranza, D., & Guerrero-Muñoz, M. (2013) · ImmunoTargets and Therapy · doi:10.2147/itt.s40131 · Cited by 14
Maghsoodi, F., Martin, T. D., & Chi, E. Y. (2023) · ACS Omega · doi:10.1021/acsomega.2c07468 · Cited by 15
Mohamed-Mohamed, H., García‐Morales, V., Sanchez-Lara, E., González‐Acedo, A., Pardo-Moreno, T., Tovar-Gálvez, M. I., Melguizo‐Rodríguez, L., & Ramos‐Rodríguez, J. J. (2023) · Neurology International · doi:10.3390/neurolint15040079 · Cited by 16
Eo, H., Lee, S.-M., Kim, S. H., Ju, I. G., Huh, E., Lim, J., Park, S., & Oh, M. S. (2022) · Food & Function · doi:10.1039/d2fo01989b · Cited by 15
Does metabolic failure at the synapse cause Alzheimer’s disease?
Engel, P. A. (2014) · Medical Hypotheses · doi:10.1016/j.mehy.2014.10.013 · Cited by 15
“in AD mouse models [70].”
Automatic segmentation of amyloid plaques in MR images using unsupervised support vector machines
Iordanescu, G., Venkatasubramanian, P. N., & Wyrwicz, A. M. (2011) · Magnetic Resonance in Medicine · doi:10.1002/mrm.23138 · Cited by 13
Chemical Engineering of Self-Assembled Alzheimer’s Peptide on a Silanized Silicon Surface
Ammar, M., Smadja, C., Ly, G. T. P., Tandjigora, D., Vigneron, J., Etchéberry, A., Taverna, M., & Dufour‐Gergam, E. (2014) · Langmuir · doi:10.1021/la500695y · Cited by 13
Corti, R., Cox, A., Cassina, V., Nardo, L., Salerno, D., Marrano, C. A., Missana, N., Andreozzi, P., Silva, P. J., Stellacci, F., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21031066 · Cited by 13
“Fluorescence studies have been mainly confined to in vivo or ex vivo plaque imaging [19,20] and assessment of their fibrillar nature using the Thioflavin T (ThT) assay [21], involving the selective staining of fibrils by the fluorescent dye ThT.”
MethodA Yeast Toxic Mutant of HET-s(218-289) Prion Displays Alternative Intermediates of Amyloidogenesis
Berthelot, K., Lecomte, S., Géan, J., Immel, F., & Cullin, C. (2010) · Biophysical Journal · doi:10.1016/j.bpj.2010.06.015 · Cited by 16
“Several studies have suggested the involvement of intermediate species such as oligomers (3–5), annular or short/quiescent fibrils (6–8), and membrane pores/channels (9,10); others have shown toxicity to be associated with mature fibrils (11,12).”
BackgroundKong, W., Mou, X., Xing, Z., Zhang, X., & Yang, Y. (2014) · Computational and Mathematical Methods in Medicine · doi:10.1155/2014/891761 · Cited by 14
“Neuroinflammation, as well as dysregulation of lipid metabolism and mitochondrial dysfunction, can also be observed [1].”
BackgroundShi, M., Chu, F., & Zhu, J. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.107960 · Cited by 15
Zhao, X., Zhang, R., Hu, D., Li, M., Liu, Y., Xiu, X., Jia, H., Wang, H., Li, Z., Liu, Y., et al. (2024) · Dyes and Pigments · doi:10.1016/j.dyepig.2024.111993 · Cited by 13
Monteiro, C. F., Gomes, M. C., Bharmoria, P., Freire, M. G., Coutinho, J. A. P., Custódio, C. A., & Mano, J. F. (2024) · ACS Nano · doi:10.1021/acsnano.4c02790 · Cited by 14
Benetik, S. F., Knez, D., Obreza, A., Košak, U., & Gobec, S. (2024) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2024.108748 · Cited by 15
Interaction between Amyloid-β Pathology and Cortical Functional Columnar Organization
Beker, S., Kellner, V., Kerti, L., & Stern, E. A. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.2426-12.2012 · Cited by 15
Njavro, J. R., Vukicevic, M., Fiorini, E., Dinkel, L., Müller, S. A., Berghofer, A., Bordier, C., Kozlov, S. O., Halle, A., Buschmann, K., et al. (2022) · Cells · doi:10.3390/cells12010079 · Cited by 17
Molecular imaging of neuroinflammation in Alzheimer’s disease
Varrone, A., & Nordberg, A. K. (2015) · Clinical and Translational Imaging · doi:10.1007/s40336-015-0137-8 · Cited by 15
Existence of different types of senile plaques between brain and spinal cord of TgCRND8 mice
Yuan, Q., Su, H., Zhang, Y., Chau, W. H., Ng, C. T., Wu, W., & Lin, Z. (2013) · Neurochemistry International · doi:10.1016/j.neuint.2013.01.006 · Cited by 13
Hematopoietic Gene Therapies for Metabolic and Neurologic Diseases
Biffi, A. (2017) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2017.06.004 · Cited by 13
Cohen, E. (2010) · Experimental Gerontology · doi:10.1016/j.exger.2010.08.032 · Cited by 13
BST2 expression at astrocyte borders promotes microglial recruitment via the C3/C3aR signaling
Zhang, S., Yuan, M., Zhou, J., Yuan, Z. K., Wang, L., Gong, C., Lu, H., Cheng, X., Wang, X., He, Q., et al. (2025) · Neuron · doi:10.1016/j.neuron.2025.09.038 · Cited by 17
Label‐free multiphoton excitation imaging as a promising diagnostic tool for breast cancer
Matsui, T., Iwasa, A., Mimura, M., Taniguchi, S., Sudo, T., Uchida, Y., Kikuta, J., Morizono, H., Horii, R., Motoyama, Y., et al. (2022) · Cancer Science · doi:10.1111/cas.15428 · Cited by 13
Brain metabolite clearance: impact on Alzheimer’s disease
Zolezzi, J. M., & Inestrosa, N. C. (2014) · Metabolic Brain Disease · doi:10.1007/s11011-014-9527-2 · Cited by 12
“Although the discussion regarding plaque burden is quite valid, the real impact of plaques remains a matter of discussion (Haass and Selkoe 2007; Meyer-Luehmann et al. 2008; Selkoe 2011; Lesné et al. 2013).”
A yeast toxic mutant of HET-s amyloid disrupts membrane integrity
Ta, H. P., Berthelot, K., Salin, B., Castano, S., Desbat, B., Bonnafous, P., Lambert, O., Alves, I. D., Cullin, C., & Lecomte, S. (2012) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2012.04.013 · Cited by 11
Berson, A., & Soreq, H. (2010) · Rambam Maimonides Medical Journal · doi:10.5041/rmmj.10014 · Cited by 12
The role of calsyntenin‐3 in dystrophic neurite formation in A lzheimer's disease brain
Uchida, Y., & Gomi, F. (2016) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.12737 · Cited by 11
Multi-scale network imaging in a mouse model of amyloidosis
Doostdar, N., Airey, J., Radulescu, C. I., Melgosa-Ecenarro, L., Zabouri, N., Pavlidi, P., Kopanitsa, M. V., Saito, T., Saido, T. C., & Barnes, S. J. (2021) · Cell Calcium · doi:10.1016/j.ceca.2021.102365 · Cited by 11
Chapter 2 Live‐Cell Imaging in the Study of Neurodegeneration
Bakota, L., & Brandt, R. (2009) · International review of cytology · doi:10.1016/s1937-6448(09)76002-2 · Cited by 13
“Further investigations revealed progressive neuritic changes over the next days to weeks (Meyer-Luehmann et al., 2008).”
BackgroundNie, H., Li, Z., Yan, Q.-X., Wang, Z., Zhao, W., Guo, L., & Yin, M. (2011) · Neurochemical Research · doi:10.1007/s11064-011-0420-7 · Cited by 13
Patel, K. R., Zhu, K., Henrion, M., Beckmann, N. D., Moein, S., Alamprese, M. L., Allen, M., Wang, X., Chan, G., Pertel, T., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.06.09.143529 · Cited by 9
“are also closely associated with amyloid beta plaques making it important to understand the cause-and-effect relationship between immune cells and AD progression[90].”
BackgroundResearch progress of kinesin family in neurological diseases
Liu, S., Chen, J., Shi, L., Deng, Y., & Wang, Z. (2025) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2025.1527305 · Cited by 12
Oporto-Colicoi, V., Sepúlveda-Lara, A., Marzuca-Nassr, G. N., & Sepúlveda, P. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262211036 · Cited by 11
Jalali, D., Guevarra, J. A., Martinez, L., Hung, L., & Vonhoff, F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22137022 · Cited by 12
Awasthi, A., Bhaskar, S., Panda, S., & Roy, S. (2024) · Brain Multiphysics · doi:10.1016/j.brain.2024.100090 · Cited by 12
Drummond, E., Muhling, J., Martins, R. N., Wijaya, L. K., Ehlert, E., & Harvey, A. R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059166 · Cited by 11
“It is known that Ab attracts and causes activation of microglia [26,27], but it has been previously suggested that this may only occur in response to fibrillar Ab [1,28,29,30].”
BackgroundLi, N., Hu, P., Xu, T., Chen, H., Chen, X., Hu, J., Yang, X., Shi, L., Luo, J., & Xu, J. (2017) · Current Alzheimer Research · doi:10.2174/1567205014666170719165745 · Cited by 11
Headmasters: Microglial regulation of learning and memory in health and disease
Weinhard, L., d’Errico, P., & Tay, T. L. (2018) · AIMS molecular science · doi:10.3934/molsci.2018.1.63 · Cited by 12
Four-dimensional microglia response to anti-Aβ treatment in APP/PS1xCX3CR1/GFP mice
García-Alloza, M., Borrelli, L. A., Thyssen, D. H., Hickman, S. E., Khoury, J. B. E., & Bacskai, B. J. (2013) · IntraVital · doi:10.4161/intv.25693 · Cited by 10
Self-citationNi, R., Chen, Z., Shi, G., Villois, A., Zhou, Q., Arosio, P., Nitsch, R. M., Nilsson, K. P. R., Klohs, J., & Razansky, D. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.02.01.929844 · Cited by 10
“Optoacoustic (29) and multiphoton microscopy techniques using methoxy-X04, BTA-1 and PIB (30-33) have been shown capable of monitoring Aβ with m resolution.”
BackgroundMethodInfluentialProtein Interactome of Amyloid-β as a Therapeutic Target
Lazarev, V. F., Dutysheva, E. A., Kanunikov, I. E., Guzhova, I. V., & Margulis, B. A. (2023) · Pharmaceuticals · doi:10.3390/ph16020312 · Cited by 9
“Some Aβ molecules are localized to the structures called senile plaques, which, according to some data, may have cytotoxic activity [3].”
BackgroundA criterion characterizing accumulated neurotoxicity of Aβ oligomers in Alzheimer's disease
Kuznetsov, A. V. (2025) · Proceedings of the Royal Society A Mathematical Physical and Engineering Sciences · doi:10.1098/rspa.2024.0652 · Cited by 11
Wang, Y., Wang, Z., Liu, Z., Li, J., Yang, S., Zhao, Y., Huang, Y., Liao, C., Zhang, Y., Zhao, J., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-63458-3 · Cited by 16
He, A., Wang, Y., Shen, Y., Dong, Z., Luo, L., Ge, X., Liu, X., Mao, Y., Zhang, T., Li, X., et al. (2025) · Nature Aging · doi:10.1038/s43587-025-01028-4 · Cited by 12
Whatever Happened to Pittsburgh Compound-A?
Klunk, W. E., & Mathis, C. A. (2008) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e318188c0c8 · Cited by 13
Model of glymphatic clearance of aggregating proteins from the brain interstitium
Mukherjee, S., & Tithof, J. (2022) · Physical review. E · doi:10.1103/physreve.105.024405 · Cited by 10
Amyloid β accelerates age-related proteome-wide protein insolubility
Anderton, E., Chamoli, M., Bhaumik, D., King, C. D., Xie, X., Foulger, A., Andersen, J. K., Schilling, B., & Lithgow, G. J. (2024) · GeroScience · doi:10.1007/s11357-024-01169-1 · Cited by 10
Linsley, J. W., Reisine, T., & Finkbeiner, S. M. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.107433 · Cited by 9
“Meyer-Luehmann et al. (82) demonstrated that microglia are recruited to plaques within days of the plaque ’ s appearance and can clear the plaques if fully activated.”
BackgroundEffect of diffusivity of amyloid beta monomers on the formation of senile plaques
Kuznetsov, A. V. (2024) · Mathematical Medicine and Biology A Journal of the IMA · doi:10.1093/imammb/dqae019 · Cited by 9
Volbracht, C., Penzkofer, S., Mansson, D., Christensen, K. V., Fog, K., Schildknecht, S., Leist, M., & Nielsen, J. (2009) · Analytical Biochemistry · doi:10.1016/j.ab.2009.01.008 · Cited by 12
Advances in Optoacoustic Neurotomography of Animal Models
Ovsepian, S. V., Olefir, I., & Ntziachristos, V. (2019) · Trends in biotechnology · doi:10.1016/j.tibtech.2019.07.012 · Cited by 9
“In terms of sensitivity and resolution, amyloid plaque imaging data with OAM are comparable to those obtained using two-photon microscopy, but showing greater penetration [67,68].”
ResultYu, Q., Liu, M., Dai, W., Xiong, Y., Mu, X., Xia, M., Li, Y., Ma, S., Su, Y., Wu, J., et al. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.974905 · Cited by 8
“At the same time, this mechanism is also related to different neurodegenerative diseases such as Alzheimer’s disease (AD) and Parkinson’s disease (PD) (Meyer-Luehmann et al., 2008).”
BackgroundMalm, T., Magga, J. M., & Koıstınaho, J. (2012) · Current Translational Geriatrics and Experimental Gerontology Reports · doi:10.1007/s13670-011-0004-z · Cited by 9
Kell, D. B., & Pretorius, E. (2016) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/057851 · Cited by 9
He, Y., Li, H., Zhang, F., Zhang, G., Tang, X., Zhu, T., Huang, N., & Li, X. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.08.025 · Cited by 8
Thymosin beta 4 prevents systemic lipopolysaccharide-induced plaque load in middle-age APP/PS1 mice
Othman, O. A., Marshall, H. J., Masterson, M., Winlow, P., Gibson, G., Ding, Y., & Pardon, M. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.109951 · Cited by 10
Liu, L.-Z., Fan, S., Gao, J., Li, W., & Xian, X. (2023) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2023.110683 · Cited by 9
Schierle, G. S. K., Sauer, M., & Kaminski, C. F. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-394431-3.00010-9 · Cited by 8
“[3] Meyer-Luehmann M, Spires-Jones TL, Prada C, Garcia-Alloza M,”
BackgroundCellular model of Alzheimer's disease — Relevance to therapeutic testing
Marwarha, G., & Ghribi, O. (2011) · Experimental Neurology · doi:10.1016/j.expneurol.2011.11.011 · Cited by 8
Endres, K., Reinhardt, S., Geladaris, A., Knies, J., Grimm, M. O. W., Hartmann, T., & Schmitt, U. (2016) · BMC Neuroscience · doi:10.1186/s12868-016-0280-9 · Cited by 10
Mori, H., Yoshino, Y., Iga, J., Ochi, S., Funahashi, Y., Yamazaki, K., Kumon, H., Ozaki, Y., & Ueno, S. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230078 · Cited by 9
Khandekar, N., Lie, K. H., Sachdev, P. S., & Sidhu, K. (2011) · Stem Cells and Development · doi:10.1089/scd.2011.0564 · Cited by 11
Chang, Y., Huang, C., Chen, N.-C., Lin, K., Huang, S., Chang, Y., Hsu, S., Chang, W., Lui, C., Hsu, C.-W., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0149056 · Cited by 9
“In transgenic mouse models [38] and human studies of AD [39–41], evidence of glial activation surrounding the amyloid deposition has been found in the cortices.”
BackgroundIntravital Imaging of Myeloid Cells: Inflammatory Migration and Resident Patrolling
Deniset, J., & Kubes, P. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.mchd-0042-2016 · Cited by 9
“In experimental Alzheimer’s disease, imaging studies have noted microglia being recruited to a plaque within the first 48 h, where they activate locally, contributing to neural loss in a CX3CR1dependent fashion (139, 140).”
Biomarkers for Alzheimer’s Disease
Farooqui, A. A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809937-7.00007-0 · Cited by 9
Correlation Analysis between External Factors and Students’ Physics Learning Achievement
Karyadi, K., Sinon, I. L. S., Yusuf, I., & Widyaningsih, S. W. (2018) · Scientiae Educatia · doi:10.24235/sc.educatia.v7i1.2415 · Cited by 10
Lee, M. K., & Chen, G. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25095004 · Cited by 6
Han, S., Byun, M. S., Yi, D., Jung, J., Kong, N., Chang, Y. Y., Keum, M., Jung, G. J., Lee, J.-Y., Lee, Y. S., et al. (2024) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2024.131 · Cited by 8
Neuronal Impulse Theory and Alzheimer’s Disease
Barz, H. (2014) · Journal of Alzheimer’s Disease & Parkinsonism · doi:10.4172/2161-0460.1000134 · Cited by 7
“They could show that in a mouse model plaques are formed “extraordinarily quickly, over 24 h” [17].”
BackgroundResultInfluentialPostupna, N. O., Latimer, C. S., Keene, C. D., Montine, K. S., Montine, T. J., & Darvas, M. (2018) · Neuromethods · doi:10.1007/978-1-4939-8739-9_17 · Cited by 7
“A uthor M anuscript A uthor M anuscript A uthor M anuscript A uthor M anuscript The relationship between PHF-τ-containing neurofibrillary tangles and impairment in synaptic function is less clear.”
BackgroundInfluentialAccurate and Unbiased Quantitation of Amyloid-β Fluorescence Images Using ImageSURF
O'Mara, A., Collins, J. M., King, A. E., Vickers, J. C., & Kirkcaldie, M. (2018) · Current Alzheimer Research · doi:10.2174/1567205016666181212152622 · Cited by 7
Metadata
- Authors
- Meyer-Luehmann, M., Spires-Jones, T. L., Prada, C., Garcia-Alloza, M., de Calignon, A., Rozkalne, A., Koenigsknecht-Talboo, J., Holtzman, D. M., Bacskai, B. J., & Hyman, B. T.
- Affiliations
- Harvard University (US)
- Washington University in St. Louis (US)
- Corresponding author
- Hyman, Bradley T.
- Venue
- Nature
- Published
- 2008-02
- Volume
- 451
- Issue
- 7179
- Pages
- 720-724
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC3264491
- OpenAlex
- W2107015337
- Cited by
- 987
- References
- 27
- Citations by year
- 2026: 27 · 2025: 25 · 2024: 45 · 2023: 38 · 2022: 45 · 2021: 56 · 2020: 43 · 2019: 40 · 2018: 37 · 2017: 36 · 2016: 57 · 2015: 51 · 2014: 48 · 2013: 62 · 2012: 83
- FWCI
- 66.09
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, other-oa)
- Funders
- Alzheimer's Association
- University of Pittsburgh
- National Institutes of Health
- National Institute on Aging (R01AG008487, P50AG005134, P30AG062421)
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK056341)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- Alzheimer's disease, amyloid plaques, microglial activation, microglial recruitment, APP/PS1 mice, amyloid hypothesis, cortical degeneration
- MeSH terms
- Alzheimer Disease, Animals, Axons, Disease Models, Animal, Mice, Transgenic, Time Factors, Amyloid beta-Peptides, Neurites, Microglia, Disease Progression, Mice, Plaque, Amyloid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.